Copertina

Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ming‐Whei Yu, Wan‐Jung Wu, Chih‐Lin Lin, Chun‐Jen Liu, Wei‐Ya Peng, Pin‐Yu Huang, Yi‐Wen Huang, Jui‐Ting Hu, Hung‐Chuen Chang, Jyh‐Ming Liou
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Hepatology Research
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Antibiotic Resistance in Helicobacter pylori in the Asia‐Pacific Region: A Call for Coordinated Regional Strategies
di: Koji Otani, et al.
Pubblicazione: (2025)

Body mass index of 23 or greater is relevant to hepatic steatosis and fibrosis in patients with harmful alcohol use
di: Keisuke Kakisaka, et al.
Pubblicazione: (2024)

Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B
di: Tyng‐Yuan Jang, et al.
Pubblicazione: (2025)

A comparative study of hepatic steatosis using two different qualitative ultrasound techniques measured based on magnetic resonance imaging‐derived proton density fat fraction
di: Sadanobu Ogawa, et al.
Pubblicazione: (2024)

Medical Costs Increase Over Time for Primary Biliary Cholangitis Patients: A 20‐Year Population‐Based Study
di: Jur‐Shan Cheng, et al.
Pubblicazione: (2026)

Loss of seroprotective antibody after a full series of hepatitis A virus vaccination in people with HIV
di: Chien‐Ching Hung
Pubblicazione: (2024)

Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium‐90 resin microspheres in Taiwan: data from the RESIN registry
di: Rheun‐Chuan Lee, et al.
Pubblicazione: (2024)

Novel protocol for prevention from hepatitis B reactivation following living‐donor liver transplantation
di: Takuma Izumi, et al.
Pubblicazione: (2024)

Distinct characteristics of various autoimmune liver diseases: A 22‐year hospital‐based study in Taiwan
di: Ming‐Ling Chang, et al.
Pubblicazione: (2024)

Gastric neoplasm detection of computer‐aided detection‐assisted esophagogastroduodenoscopy changes with implement scenarios: a real‐world study
di: Li Huang, et al.
Pubblicazione: (2024)

Performance of the GALAD Model in an Asian Cohort Undergoing Hepatocellular Carcinoma Surveillance: A Prospective Cohort Study
di: Wei‐Lun Liou, et al.
Pubblicazione: (2025)

Two‐stage deep‐learning‐based colonoscopy polyp detection incorporating fisheye and reflection correction
di: Chen‐Ming Hsu, et al.
Pubblicazione: (2024)

Limited use of FIB‐4 index in patients under 65 years of age with type 2 diabetes mellitus
di: Mimi Kim, et al.
Pubblicazione: (2024)

Tranexamic Acid With Acid Suppression Versus Acid Suppression Alone as Therapy for Upper Gastrointestinal Bleeding: A Meta‐Analysis of Randomized Controlled Trials
di: Sheau‐Wen Kan, et al.
Pubblicazione: (2024)

Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease
di: Hongsheng Yu, et al.
Pubblicazione: (2024)

Increased Prevalence of Barrett's Esophagus in Taiwan: A Prospective Multicenter Study
di: Fu‐Jen Lee, et al.
Pubblicazione: (2025)

The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy
di: Chun‐Ting Ho, et al.
Pubblicazione: (2024)

Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability
di: Jiwon Yang, et al.
Pubblicazione: (2024)

Optimal treatment strategy and prognostic analysis of salvage liver transplantation for patients with early hepatocellular carcinoma recurrence after hepatectomy
di: Hao‐Chien Hung, et al.
Pubblicazione: (2024)

Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period
di: Kazuma Mori, et al.
Pubblicazione: (2024)

Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection
di: Tatsuo Kanda, et al.
Pubblicazione: (2024)

Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
di: Yi‐Ting Chen, et al.
Pubblicazione: (2024)

Kinetics of the hepatitis B core‐related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide
di: Norio Itokawa, et al.
Pubblicazione: (2024)

Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents
di: Hideko Ohama, et al.
Pubblicazione: (2024)

Associations of serum carotenoids with cardiovascular disease mortality among patients with metabolic dysfunction‐associated steatotic liver disease
di: Qian‐Qian Wang, et al.
Pubblicazione: (2025)

Factors associated with low hepatitis B surface antigen levels in chronic hepatitis B patients treated with nucleot(s)ide analogs
di: Takanori Suzuki, et al.
Pubblicazione: (2024)

Fulminant hepatitis in a hepatitis B surface antigen‐positive patient with adult T‐cell leukemia‐lymphoma after mogamulizumab monotherapy
di: Takahiro Nakashima, et al.
Pubblicazione: (2024)

Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease
di: Meng‐Lun Hsieh, et al.
Pubblicazione: (2026)

Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis
di: Qi‐Hang Cao, et al.
Pubblicazione: (2024)

Efficacy of antiviral therapy for the prevention of mother‐to‐child transmission of hepatitis B virus and the risk of postpartum hepatitis flare after discontinuation of antiviral therapy
di: Hayato Kawamura, et al.
Pubblicazione: (2024)

A nation‐wide medical record database study: Value of hepatitis B surface antigen loss in chronic hepatitis B patients in Japan
di: Kinya Okada, et al.
Pubblicazione: (2024)

Sequential Treatment of Metastatic Colorectal Cancer in Taiwan: Real‐World Evidence From Regorafenib and Trifluridine/Tipiracil Use
di: Ya‐Wen Chang, et al.
Pubblicazione: (2025)

Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease
di: Nobuharu Tamaki, et al.
Pubblicazione: (2024)

A case of A20 haploinsufficiency complicated by autoimmune hepatitis
di: Taisei Iwasa, et al.
Pubblicazione: (2024)

Expression patterns of hepatic Mac2‐BP in the liver microenvironment
di: Tomoko Tadokoro
Pubblicazione: (2025)

Comment on “The Efficacy and Safety of Endoscopic Submucosal Dissection (ESD) Combined With Radiofrequency Ablation (RFA) Sequential Therapy for Extensive Esophageal Lesions”
di: Jing‐Yu Zhu, et al.
Pubblicazione: (2025)

Endoscopic Mucosal Resection Using an Over‐the‐Scope Clip for Duodenal Neuroendocrine Tumors: A Promising Method
di: Yi‐Heng Yao, et al.
Pubblicazione: (2025)

Clinical Trial: The Optimal Timing of the Endoscope Insertion After Oral Lidocaine Spray. A Randomized Controlled Trial
di: Hsueh‐Chien Chiang, et al.
Pubblicazione: (2025)

Prediction of intrahepatic covalently closed circular DNA levels in patients with resolved hepatitis B virus infection: Impact of serum antibody to hepatitis B core antigen titers
di: Sung Kwan Bae, et al.
Pubblicazione: (2024)

Spatiotemporal trends in the burden of colorectal cancer incidence and risk factors at country level from 1990 to 2019
di: Quanmei Li, et al.
Pubblicazione: (2024)